Philip Morris
Impact of Long-Term Filter Cigarette Usage on Lung and Larynx Cancer Risk: A Case-Control Study
Fields
- Author
- Stellman, S.D.
- Wynder, E.L.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- Area
- CORPORATE SECRETARY/FILE ROOM
- Document File
- 2083038652/2083039227/Smoking & Health Scientific Research 700000 to 790000 Published Literature Charles R. Wall Shb, 961100
- Litigation
- Feda/Produced
- Characteristic
- EXTR, EXTRA
- Site
- N2
- Named Organization
- Al Univ Hospital
- Courant Computing + Mathematics Center
- Francis Delafield Hospital
- Ftc, Federal Trade Commission
- Manhattan Veterans Administration Hospit
- Metropolitan Hospital
- Miami Veterans Hospital
- Mount Sinai Medical Center
- NCI, Natl Cancer Inst
- Ny Memorial Hospital
- Ny Univ
- Public Health Service
- St Lukes Hospital
- Tx Md Anderson Hospital + Tumor Inst
- Univ of Ca Los Angeles Hospital
- Univ of Miami Hospital Center
- US Dept of Energy
- Veterans Administration Hospital + Chari
- Author (Organization)
- Ahf, American Health Foundation
- J Natl Cancer Inst
- Named Person
- Austin, E.
- Austin, H.
- Baum, G.
- Beattie, F.
- Breslow, L.
- Hirsche, S.
- Kupler, S.
- Ochsner, A.
- Peacock, P.B.
- Peck, E.
- Rawson, R.W.
- Rednor, C.
- Saphier, N.
- Spritz, N.
- Master ID
- 2083038653/9226
- 2083038653-9226 Smoking & Health Scientific Research 700000 to 790000 Published Literature
- 2083038661-8664 Carcinoma of the Lung in Women
- 2083038665-8666 Carcinoma of the Lung in Women
- 2083038668-8681 Effects of Cigarette Smoking in Dogs
- 2083038682-8683 Effects of Cigarette Smoking on Dogs: I. Design of Experiment, Mortality, and Findings in Lung Parenchyma
- 2083038685-8698 Effects of Cigarette Smoking on Dogs II. Pulmonary Neoplasms
- 2083038699-8700 Effects of Cigarette Smoking on Dogs II. Pulmonary Neoplasms
- 2083038702-8709 Long-Term Smoking in the Donkey Effect on Tracheobronchial Particle Clearance
- 2083038710 Long-Term Smoking in the Donkey: Effect on Tracheobronchial Particle Clearance
- 2083038712-8717 Smoking and Cancer of the Lower Urinary Tract
- 2083038718-8720 Coffee-Drinking and Cancer of the Lower Urinary Tract
- 2083038722-8738 A Study of Tobacco Carcinogenesis Xi. Tumor Initiators, Tumor Accelerators, and Tumor Promoting Activity of Condensate Fractions
- 2083038739-8741 A Study of Tobacco Carcinogenesis Xi. Tumor Initiators, Tumor Accelerators, and Tumor Promoting Activity of Condensate Fractions
- 2083038743 Environmental Factors in Respiratory Disease
- 2083038744-8765 Chapter 12. Smoking Habits and Air Pollution in Relation to Lung Cancer
- 2083038766-8767 Environmental Factors in Respiratory Disease: Chapter 12. Smoking Habits and Air Pollution in Relation to Lung Cancer
- 2083038769-8775 Trends in Mortality Among British Doctors in Relation to Their Smoking Habits
- 2083038776 Trends in Mortality Among British Doctors in Relation to Their Smoking Habits
- 2083038778-8779 Smoking and Laryngeal Cancer
- 2083038780 Smoking and Laryngeal Cancer
- 2083038782-8792 Less Harmful Ways of Smoking A Workshop of the Second World Conference on Smoking and Health Held in London, England 710920 - 710924
- 2083038793-8794 Less Harmful Ways of Smoking: Tumor Promoters in Tobacco and Cigarette-Smoke Condensate
- 2083038796-8798 Risk of Lung Cancer According to Histologic Type and Cigarette Dosage
- 2083038800 Biological Effects of Asbestos Proceedings of A Working Conference Held at the International Agency for Research on Cancer, Lyon, France, 721002 - 721006
- 2083038801-8806 Relation of Cigarette Smoking to Risk of Death of Asbestos-Associated Disease Among Insulation Workers in the United States
- 2083038807-8808 Biological Effects of Asbestos. Considerations of Etiological Mechanisms and Other Factors: Relation of Cigarette Smoking to Risk of Death of Asbestos-Associated Disease Among Insulation Workers in the United States
- 2083038810-8861 Investigations on the Effects of Chronic Cigarette-Smoke Inhalation in Syrian Golden Hamsters
- 2083038862-8864 Investigations on the Effects of Chronic Cigarette-Smoke Inhalation in Syrian Golden Hamsters
- 2083038866-8871 Effects of Cigarette Smoke Components on Bronchial Clearance in the Donkey
- 2083038872-8873 Effects of Cigarette Smoke Components on Bronchial Clearance in the Donkey
- 2083038875-8881 Relation of Smoking and Age to Findings in Lung Parenchyma: A Microscopic Study
- 2083038883-8895 Alveolar Cell Hyperplasia in the Lungs of Smoking Dogs
- 2083038896-8897 Alveolar Cell Hyperplasia in the Lungs of Smoking Dogs
- 2083038899-8919 Experimental Lung Cancer Carcinogenic and Bioassays International Symposium Held at the Battelle Seattle Research Center Seattle, Wa, Usa, 740623 - 740624 Carcinogenicity of Inhaled Cigarette Smoke in the Nmu-Pretreated Hamster Larynx
- 2083038920-8922 Carcinogenicity of Inhaled Cigarette Smoke in the Nmu-Pretreated Hamster Larynx
- 2083038924-8927 Pathologic Changes in the Peripheral Airways of Young Cigarette Smokers
- 2083038928 Pathologic Changes in the Peripheral Airways of Young Cigarette Smokers
- 2083038930-8944 Smoking and Mortality Among U.S. Veterans
- 2083038945-8946 Smoking and Mortality Among U.S. Veterans
- 2083038948-8956 Tumor Induction in Tracheal Grafts: A New Experimental Model for Respiratory Carcinogenesis Studies
- 2083038957-8958 Tumor Induction in Tracheal Grafts: A New Experimental Model for Respiratory Carcinogenesis Studies
- 2083038960-8976 Strain Differences in the Response in Inbred Syrian Hamsters to Cigarette Smoke Inhalation
- 2083038977 Strain Differences in the Response in Inbred Syrian Hamsters to Cigarette Smoke Inhalation
- 2083038979-8981 Brief Communication: Synergistic Effects Benzo(A)Pyrene and Diethylnitrosamine on Respiratory Carcinogenesis in Hamsters
- 2083038982-8983 Synergistic Effects of Benzo(A)Pyrene and Diethylnitrosamine on Respiratory Carcinogenesis in Hamsters
- 2083038985-8991 Chemical Studies on Tobacco Smoke. Xxvi. On the Isolation and Identification of Volatile and Non-Volatile N-Nitrosamines and Hydrazines in Cigarette Smoke
- 2083038992 Chemical Studies on Tobacco Smoke: Xxvi. On the Isolation and Identification of Volatile and Non-Volatile N-Nitrosamines and Hydrazines in Cigarette Smoke
- 2083038994-9000 Pulmonary Function: Relation to Aging, Cigarette Habit, and Mortality
- 2083039001 Pulmonary Function: Relation to Aging, Cigarette Habit, and Mortality the Framingham Study
- 2083039003-9010 Cytoplasmic Inclusions in Pulmonary Macrophages of Cigarette Smokers
- 2083039011 Cytoplasmic Inclusions in Pulmonary Macrophages of Cigarette Smokers
- 2083039013-9020 Comparison of Proteolytic Enzyme Activity in Pulmonary Alveolar Macrophages and Blood Leukocytes in Smokers and Nonsmokers
- 2083039021-9022 Comparison of Proteolytic Enzyme Activity in Pulmonary Alveolar Macrophages and Blood Leukocytes in Smokers and Nonsmokers
- 2083039024-9027 Leukocyte Recruitment to Airways by Cigarette Smoke and Particle Phase in Contrast to Cytotoxicity of Vapor
- 2083039028-9029 Leukocyte Recruitment to Airways by Cigarette Smoke and Particle Phase in Contrast to Cytotoxicity of Vapor
- 2083039031-9037 Effects of Cigarette Smoking on Aryl Hydrocarbon Hydroxylase Activity in Lungs and Tissues of Inbred Mice
- 2083039038-9040 Effects of Cigarette Smoking on Aryl Hydrocarbon Hydroxylase Activity in Lungs and Tissues of Inbred Mice
- 2083039042-9047 Histologic Type of Lung Cancer in Relation to Smoking Habits, Year of Diagnosis and Sites of Metastases
- 2083039048 Histologic Type of Lung Cancer in Relation to Smoking Habits, Year of Diagnosis and Sites of Metastases
- 2083039050-9057 Symposium Nutrition in the Causation of Cancer Held at the Key Biscayne Hotel Key Biscayne, Florida 750519 - 750522 Some Aspects of the Epidemiology of Esophageal Cancer
- 2083039058-9060 Some Aspects of the Epidemiology of Esophageal Cancer
- 2083039062-9069 "Smokers' Larynx" and Carcinoma of the Larynx in Syrian Hamsters Exposed to Cigarette Smoke.
- 2083039070-9071 "Smokers' Larynx" and Carcinoma of the Larynx in Syrian Hamsters Exposed to Cigarette Smoke
- 2083039073-9084 "Tar" and Nicotine Content of Cigarette Smoke in Relation to Death Rates
- 2083039085-9088 "Tar" and Nicotine Content of Cigarette Smoke in Relation to Death Rates
- 2083039090-9102 Mortality in Relation to Smoking: 20 Years' Observation on Male British Doctors
- 2083039103-9107 Mortality in Relation to Smoking: 20 Years' Observation on Male British Doctors
- 2083039109-9117 Effects of Tobacco Smoke on Chemotaxis and Glucose Metabolism of Polymorphonuclear Leukocytes
- 2083039118-9119 Effects of Tobacco Smoke on Chemotaxis and Glucose Metabolism of Polymorphonuclear Leukocytes
- 2083039121-9128 Possible Mechanisms of Emphysema in Smokers Cigarette Smoke Condensate Suppresses Protease Inhibition in Vitro
- 2083039130-9135 Etiological Factors in Oral Squamous Cell Carcinoma
- 2083039136-9137 Etiological Factors in Oral Squamous Cell Carcinoma
- 2083039139-9145 A Study of Tobacco Carcinogenesis. Xv. Effects on N' - Nitrosonornicotine and N' - Nitrosoanarasine in Syrian Golden Hamsters
- 2083039146-9147 A Study of Tobacco Carcinogenesis. Xv. Effects on N' - Nitrosonornicotine and N' - Nitrosoanarasine in Syrian Golden Hamsters
- 2083039149-9151 Mortality Among Doctors in Different Occupations
- 2083039152-9154 Mortality Among Doctors in Different Occupations
- 2083039156-9163 Alpha, - Antitrypsin Deficiency in Nonsmokers
- 2083039164-9165 Alpha1-Antitrypsin Deficiency in Nonsmokers
- 2083039167-9175 Possible Mechanisms of Emphysema in Cigarette Smokers Release of Elastase From Human Polymorphonuclear Leukocytes by Cigarette Smoke Condensate in Vitro
- 2083039177-9181 Possible Mechanisms of Emphysema in Smokers in Vitro Suppression of Serum Elastase-Inhibitory Capacity by Fresh Cigarette Smoke and Its Prevention by Antioxidants
- 2083039182-9183 Possible Mechanisms of Emphysema in Smokers: in Vitro Suppression of Serum Elastase-Inhibitory Capacity by Fresh Cigarette Smoke and Its Prevention by Antioxidants
- 2083039185-9192 The Effect of Tobacco Smoke on the Metabolism and Function of Rat Alveolar Macrophages
- 2083039193-9194 The Effect of Tobacco Smoke on the Metabolism and Function of Rat Alveolar Macrophages
- 2083039196-9200 The "Urban Factor" and Lung Cancer: Cigarette Smoking or Air Pollution?
- 2083039201 The 'Urban Factor' and Lung Cancer: Cigarette Smoking or Air Pollution?
- 2083039203-9208 Tobacco-Specific Nitrosamines: Formation From Nicotine in Vitro and During Tobacco Curing and Carcinogenicity in Strain A Mice
- 2083039209-9211 Tobacco-Specific Nitrosamines: Formation From Nicotine in Vitro and During Tobacco Curing and Carcinogenicity in Strain A Mice
- 2083039213-9214 Human Pulmonary Alveolar Macrophages Metabolise Benzo(A) Pyrene to Proximate and Ultimate Mutagens
- 2083039215-9216 Human Pulmonary Alveolar Macrophages Metabolise Benzo(A) Pyrene to Proximate and Ultimate Mutagens
- 2083039225-9226 Impact of Long-Term Filter Cigarette Usage on Lung and Larynx Cancer Risk: A Case-Control Study
Related Documents:
Document Images
Impact of Long-Term Filter Cigarette Usage on Lung and Larynx
~ Cancer Risk: A Case-Control Study 1, 2
Ernst L. Wynder, M.D., I and Steven D. Stellman, Ph.D.
ABSTRACT-A case-control study was conducted among 1,034
white male and female hospital patients with histologically proved
lung cancer (Kreyberg type I) or larynx cancer. After adjustment
for duration ol the smoking habit, inhalation, and butt length,
relative risks of developing lung or larynx cancer were consis-
tently lower among long-term smokers of filter cigarettes than
among smokers o1 nonfilter cigarettes, irrespective of quantity
smoked. Relative risks in alt groups declined with increased years
of smoking cessation. The observed risk reduction among cur-
rent smokers ol filter cigarettes was consistent with that e.-
pected, considering that these persons had smoked the older
high-tar nonfiller cigarettes for a large proportion of their lives.-
J Nall Cancer Inst 62: 471-477, 1979.
Although ctgarette smoking is recognized as the
major causative factor of lung and larynx cancer in
both men and women (1), elimination of cigarette
smoking does not at present appear to be a social
possibility, Therefore, :ts Gori (2) has pointed out,
alternative strategies must be sought as a humane but
interim approach to the cornplex problem nf preven-
ting tobac(o-related disease. "I-wo such strategies con-
tinue to be explored widely: a) persuading segments of
the population to reduce their consumption of ciga-
rettes rettes or to quit altogether (behaeioral), and 6) modify-
ing the cigarette itself to produce a"less harmful ciga-
rette" (managerial). The effects of both approaches on
the risk of developing tobacco-related cancer have been
intensively studied for a number of years. In this paper
we examine the impact that the less harmful cigarette
has thus far had on the risk of developing lung or
larynx cancer, and we attempt to predict the future
disease patterns that may emerge from continued appli-
cation of the managerial approach to cancer preven-
tion.
The rationale underlying this assessment is the dose-
response effect obserced in both prospective and retro-
spective studies; the greater the exposure (as n)easured,
e.g., by the average number of cigarettes smoked per
day or by duration of the smoking habit), the greater
the risk of lung or other tobacco-related cant'er.s (J-6).
Thus as exposure decreases, either by smoking fewer
cigarettes or by smoking cigarettes significantly lower
in yield of tmnorigenic components, a proportiomttely
lower risk of developing tobacco-related cancers should
be expected.
In this regard, two major events have occurred over
the past 20 years: Consumption of cigarettes with lower
tars has increased (7-10), and the tumorigenic potential
of tar has dea'eased (10-12). Earlier studies have shown
that a lower lung and larynx cancer risk exists among
long-term smokers of filter cigarettes than among
smokers of nonfilter brands (13-16). We provide further
~evidence, encouraging in light of the growing popu-
larity of lower tar cigarettes.
MATERIALS AND METHODS
The data corutilute a portion of that collected in an
ongoing rett<rsprtrice stud}uf tobacco-related c:utcer.
{Y'ith the use uf a standard questionnare, interviews
were conducted from 1969 to 1976 in six U.S. cities by
personnel who had undergone a detailed and uniform
training period at our institute. Approximately one-
third of all interviewed patients were at Memorial
Hospital, and decreasingly smaller numbers eeere in
carious hospitals in Houston, Los Angeles, New York,
Birmingham, Miami, and New Orleans. Interviel.ers
visited J3~ of the coherent lung and larynx cancer
patients admitted to these hospitals.
The numbers of cancer patients and controls are
shown in table 1 with their age distributions. There
were 68-4 lung cancer cases and 350 larcnx cancer cases,
All patients had histopathologic confirmation of cliag-
nosis. For the analysis in this paper, only lireyberg type
I lung cancer (squamous und oat cell types) was,
considered beawne this type has been shown to exhibit
Aausrvoeuuss rstn. t:rTS=long-term (ilter cigarrue .moker(si;
NFS=non(iltet <igareuc smukcr(bl.
~ Receivttl \huth 29, 1976: ucceptrd September 3, 197R.
' Supported by Public Ftealth Service contract N0t-CP55666 and
grant CA776t3 front the National Cmcer Institute. Computations
were performcd in parl .u the C:ourant Computing and Mathematic's
Ccnter (New York t!niversity), which is supported hy C.S. Deparo-
ment of Energy contract EY-76-C-02-9077.
r Dirision of P.pidcnriologY, Naylur Dana Insriwte for Disease
Ptevention. :lmeriedn Ilr,lth Fuuodation, Y20 F.ant i9d St., \ew
S'urk, N'.Y. 10017
.
' Dicision of Biostativics, Naylor Dana instiurte for Disease
Pre.cntiun.
s SS'e thunk Mr. H:ulaud Austin and Sts. IVaney Saphier for excel-
lent scui,tYral and prugramming ussistance. We also acknowledge the
mnnibwiuu. uf ihc fulluwiug institutloru :md indiciduals-New
Ynrk. N.Y.'. llcntmLd (luapit:d, I)r. I(. lk'aniet \tount Sinai 1.h.vlic:d
Crntrq 1)r. 9hridun 6up(er; hluohattan S'eteruns AtL»inistratiun
Ho.spual, Dr. (:h:ules Rednnr and Dr. Surton Spritc Fraucis
nrlutiold ILuspinil, kG. Esthvr Au,tiu; Mctrapuliwn Hnspitul, Dr.
.Sigmwtde IlirscLe: St. L.ukeS Ituspital, Sts. Evelyn Peck. blinmi,
Plu.: }liurni Venr:ms 1-lospilal arid Iprirersity of Miumi Fluspital
Cetlter, Dr. George Butun. Ilirminghum, Ala.: tOticersity Ilo.pital,
Di. Peter li. Pra<nck. Huustun, liM: \I.1). :lndcnun IluspiUd aud
Tumur In.stittue, I)r. Rulun W. Rawsnn. Lus Angeles. C:alif.:
Ilnieenity of Californiu at Los Angeles Hospital, Dr. Lester Breslow.
:vew Urleans. Lt.: S'eter:ms :\dnrinisrraiion Ilospital and Charity
I-lospitul, Dr. Alwn Ottuner.
° Tot:d particulate matter (PPAf) refers to the material separated
(rom the gaseom portion of rig',rrerre smoke hr n(ambridgc tiher,
w'hile "tar" is defined and me:uured by the L1.5. Fedefal'I7ade C:nnt-
misaiun as 7PN1 Iess mutature and nicotine.
N
O
O
W
O'
W
N
~
00
VOL. 62. NO. 3. MARCIt 1979 471 J NA'l'l. ('.ANCER [NSr

472 Wynder and Sfellman
TABLE 1.-Num6er of cancer and control patients Nho were either
lifetime nonsmokers, rurrent smokers. or ex-smokers,
b2j age and sex
1* Lung' cancer
ti
t Larynx° cancer
i
Controls
Age, yr en
s
pa pat
ents
Male Female Male Female Male Female
<50 72 29 41 15 1,533 1.617
50-59 191 46 108 22 1,402 1,301
60-69 215 32 93 24 1.318 1,104
70-89 79 20 44 3 582 690
Total 557 127 286 64 4,835 4,712
0
0
° Kreyberg type I.
° Glottic and supraglottic types.
the strongest dose response of all tobacco-related cancers
(6, 14). The larynx cancer cases included both glottic
and supraglottic types because both have been shown to
be equally related to tobacco usage (I3).
Controls were selected on the basis of absence of a
history of tobacco-related disease. Tobacco-related
LUNC CANCER tl(aEYOEAG TYPE L), t'Jil.ES
NO OF CIGARETTES SMOKED PER DAY
SMOKER 1-10 11-20 2N0 31-40
LI1KG CPNLER (KREY8F.0.C TYPE t). FCIALES
20
20 0
disease was defined as a cancer of lung, larynx, mout
esophagus, or bladder [which comprised the cases i
our prerious report (6)1; cancer of the pancreas, licl
or kidney; myocardial infarction; stroke. ~Wriphll
vascular disease, or abdominal aortic anI <hion
bronchitis or chronic obstructive pultnonary diseasgastric ulcer; or cirrhosis of the liver. The
diagnoses I
9,547 eligible controls were distributed as follon
(numbers in parentheses are percentages for males ar
females, respectively): cancer of the stomach 12. ~
colon or rectum_IZ. 5). prostate gland (6, 0), breast (
13), cervix (0, 10), or skin, including melanoma (6, {
leukemia, lymphoma, or Hodgkin's disease (7, 4); oth
cancers, e;g., cancer of the male or femalr reproducti1
organs (9, ll); benign neoplastic diseases (1I, II
fractures (8, 6); or other nonneoplastic diseases, e.g
burns, infections, or duodenal ulcers (14, 34).
The major index of response to cigarette smokir
was expressed as the relative risk, defined as the rat;
of the incidence of lung or larynx cancer amor
smokers to its incidence among nonsmokers. Poii
LARYNF CANCER, MALES
30
25
1
nER I F NF F NF F NF
SMo 10 II-20 21-.10 31-40
NO OF CIGARETTES SMOKED PER DAY
LARYNX CANCER FEMALES
45
35
25
15
5
(9)
ND OF CIGARETTES SMOKED PER DAY NO OF CIGARETTES SMOKED PER DAY
Texr.eteoaz I.-Age-adjusted relative risk of lung or larynx cancer for LTFS and NFS by quantity
smoked. Fraction=No. cases: No. contro
F=filter cigarettes, NF=nonfilter cigaretres. A) Lung cancer, males; No. cases=143 LTFS. 150 NFS. B)
Larynz cancer, mates; No. cases=l
LTFS, 86 NFS. C) Lung cancer, females; No. cases=50 LTFS, 18 NFS. D) Larynx cancer, females; No.
cascs=20 LTFS, 17 NF
J NATL CANCER INST
VOL. 62. NO. 3, MARCH 19

Less Harmful Cigarettes 473
~
9
estimates of relative risk were made by means of odds
ratios; potentially confounding variables (e.g., age)
were controlled by use of either the iVtantel-Haenszel
method (17) or the iVliettinen confounder score method
(18). Interval estimates of relative risk were made by the
method of Gart (19).
This study included all interviewed white patients
who were either non.smokcrs (n(,vcr .smokcd any' tobac-
eo product regularly), ex-smokers (quit at least 1 year
prior to interview), or current cigarette smokers. Persons
who had regulatly smuked only cig;us or pip(s weit
excluded, but uot eigateue sniukers who alw used
cigars or pipes. To ass«re that the known latency
period for most tobacco-related cancers was exceeded,
we restricted the smoker and ex-smoker groups to
people who had smoked cigarettes for at least 20 years.
RESULTS
Relative Risks Among LTFS and NFS
Age-adjusted relative risks were estimated separately
[or LTFS (defined as present smokers who used filter
cigarettes currently and for at least 10 years) and NFS
(defined as present smokers whose current brand was
nonfilter). Age categories used in the adjustment were:
20-49, 50-59, 60-ti9, and 70-89 years. Results of these
calculations are displayed for both lung and larynx
cancer in text-figure I. In these dose-response curves,
the estimated relative risk is plotted against the quantity
smoked (clefined as the average number of cigarettes of
the (wrent brand smoked per day). Among both
females and males, the risk for both lung and larynx
cancer among LTFS was lower than that of NFS at
each of the five quantity levels in which data were
grouped.
Table 2 shows the relative risks for LTFS, expressed
as a percentage of the risk for NFS, by sex and
quantity of cigarettes smoked daily. Percent reduction
of risk is obtained by subtracting this quantity from
100%. Among male LTFS, reduction of risk ranged
from I1 to 39'. for lung cancer and from 25 to 49 a for
larynx cancer. Substantial lowering of risk was also
calculated for female LTFS; the one exception was
TABLE 2.-Retatire risk of lung or larynx cancer for LTFS.°
as a percentage of the relative risk for NFS. °
. by sex and quantity smoked
No. of Cancer site
cigarettes
smoked/
Lung Larynx
day Male, % Female, % Male, % Female, %
1-10 61 38
1-20 - 11
11-20 89 69 5L
21-30 71 79 53
21+ 33
31-40 ' 66 75
31+ - 103
41+ 86 - 55
0 ' Defined as present smokers who have used filter cigarettes
for ?10 years.
° Defined as present smokers whose current brand is nonfilter.
TABLE 3. Eslimated relative risk of lung and larynx cancer
among NFS, relatiae to LTFS, after adjvsting for various factors
Sex Adjustment
Odds ratio
factors° 95% Confidence
interval
Lung cancer
Male D, Q 1.19 (0.92-1.55)
Male A, Q 1.26 (0.97-1.64)
Female D, Q 1.29 (0.67-2.47)
Female A, Q 1.37 (0.72-2.60)
Larynx cancer
Male D, Q 165 (1.16-2.34)
D, Q, Ale 1.49 (1.05-2.10)
Male A, Q 1.71 (1.21-2.41)
Female D, Q 4.19 (2.66-6.61)
D, Q, Ale 3.97 (2.04-7.70)
Female A, Q 4.34 (2.27-8.31)
° By Mantel-Haenszel method, adjusted for duration (D): 20-29,
30-39, 40-49, 50-59, 60+ years; average No. of cigarettes smoked
per day (Q): 1-10, 11-20, 21-30, 31-40, 41+; age (A): 20-49,
50-59, 60-69, 70-89 years; alcohol consumption (Ale): none, 1-6
oz/day, 7+ oz/day. For females, due to the smaller number of
cases, the D categories 50-59 and 60+ were combined, as were
the Q categories 31-40 and 41+,
probably attributable to the small number of casesin
that category.
ddjustment for duration and quantity smoked.-Al-
though adjusted for age, the foregoing risk estimates
may be influenced by additional confounding by dura-
tion of smoking habit, even though age and duration are
strongly correlated. This would be true, for example, if
LTFS began smoking earlier in life than did NFS of the
same age. Additional risk estimates were made in which
both habit duration and cigarette quantity were con-
trolled, and they were compared with corresponding
estimates in which both_ age and quantity were con-
trolled. Because we were adjusting for possible differ-
ences between LTFS and NFS, the risks were calculated
with LTFS (rather than nonsmokers) as the referent.
Results are presented in table 3, in which the odds ratios
and 95% confidence intervals are given.
Adjustment for other smokireg intensity variables.-
Because tar and nicotine levels of cigarettes are highly
correlated (10), it has been suggested that persons who
switch to cigarettes with a lower tar level may subse-
quently adjust their smoking habits to compensate for
the concomitantly lower nicotine level. This compen-
sation may be manifested by an increase in the number
of cigarettes smoked per day, deeper inhalation, or
shorter butt length (indicating a greater portion of
each cigarette smoked). Odds ratios were calculated for
lung cancer by use of Miettinen's method (IS), in
which the following variables were all controlled
simultaneously: average daily quantity of cigarettes
smoked and habit duration (continuous), educatiou
(eight levels), inhalation (four levels), butt length (four
levels), and city (six levels). The resulting risk es'timates,
based on a sumntary over 10 strata of the confotmder
score, were not significantly different from those
reported in table 3. -- - -- -
Adjustmenf for alcohol coruumption.-Although the
risk for lung cancrt is greater than that for larynx
VUI.. 1,2, NO. Y MARCII 1979 J N,CrI-CANCE.k Ih:vl'

474 Wynder and Steilman
01
cancer among smokers (relati.e to nonsmokers) (6),
table 3 shows that the reducion in risk observed
among LTFS relative to NFS was actually greater for
larynx cancer. Because larynx cancer is related to use of
alcohol as well as to cigarette consumption, potential
confounding by alcohol consumption was considered.
Among controls, for example, NFS were twice as
likely as LTFS to be heavy drinkers of alcohol (7 or
more oz/day). The larynx cancer risks in table 3, after
adjustment for duration of smoking, quantity smoked,
and alcohol consumption, were reduced to 1.49 for
men and 3.97 for women when this confounding was
removed but were still significantly greater than I.
Effect of Smoking Cessation on Cancer Risk
Because maximum reduction in cancer risk is achieved
by reducing tar intake to zero, i.e., quitting smoking
altogether, relative risk estimates were made for ex-
LUNG CANCER (RftEYBERG TYPE I), MALES
YEARS CP SMOKING CESSATION
LIING CANCER ()CREYBERG TYPE I), FEMALES
1n
re(
IBF
6
C
N
FfiESEN/ i-] u-6 )-10 111 NGN
SM]M1ER SMGRER
smokers in several age strata. In these calculations it
was not possible to discriminate between former NFS
and LTFS, because_few of the latter had quit smoking
for a significant period of time. As observed previously
(6, 13), relative risk declined with years of cessation.
Because the reduction of risk was appreciably greater for
people 50-69 years old than for those 70 or more years
old, the relative risks for persons 50-69 only (stratified
into two groups, 50-59 and 60-69, and reported as a
combined risk estimate) were plotted against years of
cessation in text-figure 2. This age group included more
than two-thirds of all lung and larynx cancer patients.
The relevance of smoking cessation, particularly in
this age group, to use of the less harmful cigarette is
assessed by two observations (text-fig. 2). First, male
long-term cigarette smokers must have ceased the habit
for at least 3 years before any decline in risk could be
expected. The sizable increase in risk among males
during the first 3 years after cessation may be attrib-
LARYNX CANCER. MALES
YEARS OF SMOKING CESSATION
LARYNX GANCER. FEMALES
9
;c
0
6
2
.t,
~
~ YEARS OF SMOKING CESSATION YEARS OF SMOKING CESSATION
D
'CRxr.n<'.rue 2.-Age-adusted risk of lung or hu.nx amier for ex-smokers (50-1i9 years old) by
years of cessation. Fraetion=No. rases,No.
cnntrols. A) Lung cancer. males; No. cases='106. B) Larynx cancer, males; No. cases=20I. C) Lung
cancer. females; No. cases=7R. D) Larynx
cancer, females: No. cases=46.
J NA'fL CANCER INST
VOL. 62. NO. 3. MARCH 1979

utable to the failure of smokers with emerging signs of
clinical illness to seek medical attention until after
quitting. Second, 10-15 years of cessation are required
before the long-term smoker's risk approaches ehat of a
nonsmoker. Therefore, at least this much time must
elapse for a long-term smoker to receive maximum
benefit from switching to lower tar cigarettes. This was
our rationctle for restric'tiug ihe Cl-F;S group to persons
who had continuously smoked (ilter cigarettes (or at
least 10 years.
DISCUSSION
Whether calculated as a single summary estimate or
as a dose-responx curve, the data consistently point to
reductions in risk for lung cancer and even larger
reductions for larynx cancer risk among LTFS. As
stated previously, the maximum risk reduction that a
long-term smoker can expect is achieved orrly through
complete cessation of smoking. One who switches from
nonfilter to filter cigarettes must necessarily experience
a more modest risk reduction than an ex-smoker over
the same time period. Average tar levels of filter
cigarettes hace been abom two-thirds those of nonfilter
cigarettes for over a decade, and the tar levels for both
have declined roughly in parallel; thus a?0-80°0
lowering in risk may reasonably be expected at the
present time and was about what was observed.
The following is a diac'ussion of current and future
trends in cigarette c'omposition and smoking behavior
that may soon influence the expected patterns of
tobacco-related cancers.
Cigarette Variables
Changes in tar levels mitk time.-Wlren the first
major epidemiologic studies linking lung cancer and
cigarette smoking appeared in 1950 (5), the average
cigarette yielded about 10 mg tar. Since that time, tar
levels have fallen considerably. Text-figure 3 demon-
strates that tar levels of both filter and nonfilter
Less Harmful Cigarettes 475
cigarettes continue to fall,.and that even today's non-
filter cigarette produces one-third less tar dran the
nonfilter cigarette of a generation ago (20). This
reduction in tar has occurred not only in the United
States but throughout most of the world (10-12, ?1-2a),
as shown in studies by Kuhn and Klus (25) in Austria,
Todd in England (26), Ledez in France (personal
comnumic.uiun), Tinun in Germany (27), and Hoff-
mann iu Canada (unpublished observations).
Changes in tar aclit~ity.-Chemical and biological
experimeuts have ittdicattd that tars of present-day
cigarettes havc lower carcinogenicity per gram than
tars of 25 years ago (!, 10, 11). This lowered activity,
coupled with reduced toud yield per cigarette, has
undoubtedly t:ontribtned to a reduction in cancer risk
in some populations, as observed in this and other
studies (24).
Smoking Variables
Changes in filter cigarette consuntption,-h is not
sufficient that some of the .nailable cigarettes become
potentiallv less harmful in order to bring about a
measurable lowering of disease incidence. Smokers
rnust ako switch to those cigarettes in preference to
higher tar brmds. This appear. to be the trend. By
1976 nearly 90" of all cigarettes sold in the United
Stutes were filter brands (20, 34). The past 5 years have
witnessed ihe emergence of low-tar (<15 mg) cigarettes,
which ha~e capwred more than 16% of the market.
This trend is illustrated in text-figure d in which the
market share of all cigarettes yielding less than 15 tng
tar is plotted for the 10-year period 1967-76. The
growing usage of these cigarettes will probably have a
continuing effect on reducing the average daily tar
intake and concomitant disease risk.
Changes an lifetime tar consumption-Our studies
have not yet included persons who have smoked lower
tar cigarettes exclusively. Text-figure 5 shows a model
calculation of the proportion of a person's lifetime
_ EAR
Texl'-F¢.tur Y.-S:Jt.nrci4luert :nerage wr delio-ery of U.S fitur and nonfilter rigarettrv,
1957-78. PfC=Federul Trtde Conmussion.
J NA'rL CANCER INST
VOt-. 62, NO. tl, MANCn 1979

0
0
476 Wynder and Stetlman
16
5
4-i
I 3-V
5-i
3-i
21
67 68 69 70 71 72 73 74 75 76
YEAR
TexrFtot'Re {.-Percent m:rrket share for low-tar cigareues, 1967-76.
spent smoking filter cigarettes, on the assumption that
a typical smoker began at age 20 and switched to filter
cigarettes in 1960 when these brands achieved wide-
spread popularity. About two-thirds of lung cancer
patients currently fall between ages 50 and 69 and, as
text-figure 5 indicates, could have used filter cigarettes
for no more than 50% of their total smoking years.
Considering that the average lung or larynx cancer
patient is between 56 and 60 years old and has smoked
cigarettes for an average of 40-50 years, the risk for
developing a smoking-related cancer today probably
depends on a history that included both old and new
types of cigarettes. The relative risks should be even
lower in the future among persons who will have
smoked filter cigarettes all their lives.
Changes in smoking behavior.-Because tar and
nicotine levels in cigarette smoke are strongly correlated
(10), the simultaneous reduction of these two compo-
nents might be compensated behaviorally by increased
exposqre, e.g., deeper inhalation, more frequent puf-
fing, and leaving shorter butts. Some short-term studies
have demonstrated that all three methods can be used
by the same smoker to adjust to the new lower tar
J NATL CANCER INST
cigarette [(10, 28-30); Hill P: Unpublished obsenations].
However, long-term epidemiologic studies, including
this one, have not shown differences between LTFS
and NFS, either among lung or larynx cancer patients
or controls, in either the number of cigarettes smoked
or subjective inhalation response (though the lung and
larynx cancer patients as a group invariably consumed
more cigarettes than did the controls) (6, 28). In this
study, adjustment for inhalation and butt length did
not bring about significant changes in risk estimates.
Objective comparisons of levels of nicotine, its major
metabolite cotinine, and carboxyhemoglobin in the
sera of long-term smokers are clearly needed and are
now in progress in our laboratory. They may help to
resolve this behavioral issue by determining whether
long-term compensation for a low-nicotine cigarette
might lead to greater tar consumption.
Alternative Strategies
Although development of a less harmful cigarette
has apparently had some success in lowering the risk
of lung and larynx cancer, it must not be considered a
complete prescription for the prevention of these and
other tobacco-related diseases. Additional approaches
are needed, particularly preventive education of young
presmokers and cessation programs for curreni smokers.
At present, antismoking education is making little
headway with our youth. The number of boys who
begin smoking has remained constant over 'the last
decade, and the number of girls taking up the habit
has doubled (31). New approaches to health education
of the young are needed, such as the Know Your Body
(KYB) program initiated-by our institute, whereby each
child is involved in health promotion programs (32,
33). Antismoking propaganda among adults has been
more successful for men than for women; among the
70
I
I
u
z
Y
0
s
O
60
50
40
0
FILTER
NON-FILTER
25%
38 0
50
1895 1905
1915 1925
YEAR OF BIRTH
TexLFIGt'RE 5.-Filter cigarette usage as a percentage of total
smoking experience, by birth cohon.
VOL. 62. NO. 3, MARCH t979

0
0
more educated groups of men a significant percentage
have been able to stop smoking on their own (9).
Smoking cessation clinics have also had some success
(39, 35). Nevertheless, more than -10 million adults con-
finue to smoke in spite of all (vidence presented to
them of its adverse effects. As long as society condones
smoking, }oung people will take up the habit, and
many adults Will rontinu(!. Obviously, bet[er auli-
smoking propaganda, improved smoking cessation pro-
grams, and development of even less h:u'mful rir;:3reaes
are needed.
REFERENCES
I!) U.S, Dep:trtment of Ile:tlth, Hdut':uion, and \t'elfure: Smoking
and Hr:dth. Report uf the Adcisory C:ommiuee to the Surgou
Cruerul Of the Publi<' Ile:rlth Serriw. Puhlir Efe:rith Srrv liull
No. 1103, lt'ushiugtnn, D.C.', U.S. Govl Print Off, 19tii
(?) GuRt GB: Lotc-risk ri,K:nrues: A presrripti,rn. S<irn<r 191:1fN3-
1°_17, 1976
(3) d R.uato.cU E(:: .Smoking in ieldlion m deuth r,n<s of one ntillion
mvu and women. V:uI C:rn<er Inst Atonngr 19:I'L9-20i. 19fi(i
({) L'S. Department of Iir:dtit, Eduratinn, aud A'elf:ue: 1'Ite IIc:d11r
Cun1e(jucn<'e5of Stnokiug. CD(I) 7~1-N7&1.
I'.S Cotc Print DIf, 1971
(5) \1'sanrR I.L. (:It.tii.tsl E.1: Ibha<ro ~ntokin,g as it posOhlc
otfoluGic LrcUor in bronrhiogeni< carciuom:t. Jd)[.l 1i3.329-
Y7ti, 1950
I Lt'tmntu I.1., Slrt.ral.t~ SI): Compar:uice rpidrmioIogy Of
IoL,tuuarluled t',m<rrs, C',mrrr Res 37:I608-1022. 1977
(7) IIS. Drpaninem of lle.ihh. Nduuuiun. autl ll'clf:ur. 1'hr :\dtdi
l'sr nf 1uhaun. 1975 , .\tl.mta: C:cnter for I)isr.t.r Conue,l,
Iturr.iu Of fir:rhh F:durutiun. 1976
(8) l1's.vnrR hl.. }lut)\n~~ 1): l~uhauo and tob:nru smuAr.Srtnin
Uneul 95-19. 1976
(9) lhsolN 4:1., Cut'ts 1.5, ,\Ltts[t,m K: C:urtont snwAing h:r6ils
L)' scleurd barkKround suiahles: ['heir e[fe<t un fuune
rlisrase ^rnds. :\m J k:pidrmiui I00:IIi8-177, 1971
(10) l1'tuta I:H: Retent ehangrs in wbeuu pruducn and Iheir
aueplMI<r b)thr eunsmnrt. br Plaeevdings of the~ Siaih IWrr-
n:niuned -IulrUeto S,ieutifit' ('ungn~ss, f'ok}'o. J,rpan, 1976.
Cartsta Infonnauun Hull (sp<tizl):15-30, 1976
(11) \9vsmtt F.1., IiwtsuNN ^: Ibbnero and Iohano .Snmkc:
Studies in Lkprrimrmal (Lueiuuyeue'..is. \'rt<\'urk::\nrdrmie
Presa, 191i7
(12) : }'.sllcrimcnarl to6:rrco r:urinogenesis. Scirnce I62:802-
871, 191ik-
(I3) lVrsnrx E1., (bcis I.S. Yttxtuu K. et :tl: Hmironmeul:d
Luuns iu e:uurr of tht Iarsm'. :\ sceond luuk. C1mu.r 38:151J1-
I601, 1971i
(1I) \\lsurx 4:L, \t%nr<.ut K. Rt.ltru EJ: -I'he epidcnriology of
hwg am<rr: Roeent Irends. JAMA 213:2211_2228. 1970
(15) Bsoss If, (:rusos R: Rik of lung rnutrr in unok( .re whu>witth
to fihea ei4nirnrs. Am J Publie IlrAth 58:1:396-I102, t)I,x
(!e) Il.t.~tstmn Y.(I. (aRrrnntt. L...Stmal,ts II, rl .il', I;u tnd 11i<1-
VO1..62, NO. S. htARCli 1979
Less Harmful Cigarettes 477
tinc contt-m of (iG:rrrur smoke in retation to drnh rams.
Emiron Res I9 :21i3-27 I. 1976
117) \[%NItt N. II~twH. l\': Swtisxiral uspects of the analysis of
data 6ont retruspettise studi<s of disease. J N:nl C:anmr Insl
°:719-i18. I9G9
(18) .Ailt I ILAtN OS: lUdtlfiUrliorr by' .t multiRdriatf cunfuuntft'r CtOrt'.
Arn J L'.pidemiol I01609-620, 197fi
(19) (aet JJ: Poiul dnd unenrI rsum.tuon of the (ommou odds
r.mu iu thr eumLm:uiuu of 2X2 teWrs Kith fise<I mergina6.
Rmmrurk.r 57:171-175. 1070
(20) Atsstccrr JC Jx: l'he 1976 Alaxwell report. Tohucco Reporter
I03a16-17. Si-;i. 19;1i -
(21) Iluttolt~s I), St.uantv 1. Ilrctn SS, ci al: Ch"mical swdirs
uu ruLue<o smokr. XXXIX. On Ihr idenufitution or err<iuo-
gens, tumor pmmotrrs and e.rrrinogens in lobacco smoke. In
Prueredii~q, of tho Third \1'orld Conleremr nn 9moking and
Ilndth i1C)ardrr F.l., Ihtifm,wn Or ('ori GB, cdsl Iul I.
lt:ulun4lun. 1)C.'. 1'.S. Gusl Prim Ofl. 1976. pp 125-I15
(22) lt't:snra tl., HottsrtuaD: L.ess hurmful rcuys Of emoking.
J Nail Caneer Inu 49:I719-1758, 1972
(23) IA'rNntk EL, [ie)tt+ltNa n, Onrtt RG, eds: ProceedinGS of the
7hird AVorld Cungrem out Smukiqw, and Health, sol I.
Vt'ushington, D.Cl: U.S. Govt Print Off. 1976
(24) l4sIutt< t:L tit<,tn S. rds: Lune caneer. t'[CC 'Cedtnieal
Reporl Series, vol 25. Genec:r. Union Internation:tle Cuntre Ic
1976
(?s) Kt'u:y EL Kt.rs }{: Ke<luedun of smoke n[cotinc and snmke
eoudcns'ate in :Aurura dwrnR the pasi fifteen evrs Farhl Alitt
Orsiru LLb:rkreGie Iti.3211-329. 1975
(26) Tuuu (IF: ChsnGrs in anoAiug pa4erns in the ('.F.7ri Pro-
umdiqKs of dre EJesrnth IntenmtiuNd C.m<'er (bngress,
4lorrnu, Imlc, 1971, or<.,sionW paPer I. C.undmr. I-obzrCo
Rrsedtth Cuunril, 1975
i27l Il?rnt 4'J: [lrndumd)seu tum Prnblent des t'erbrau<h<s an
\'ikutin und Itaueld.udens:rl in drt RuudesrepuLlik Deutuh-
I.md IUu <lie J:rhre 1961 his 1975z Britr'[Cub:rkfurarlrtl:101-Ibl,
B7(i
(_^Y) :\us\n PI: ChHUges in peranral ~mukrng huhits brouKht about
In thzn.Rrn in rigzreue smuke )irld. In Procer<lings of Ihr
Slrrh Intemutiunul Cub'.ntu .S<irutific Cnngrrsv. Cnkyo,
J:tp:nr, 1976. Curesta lufnrnuni<rn Rull I.spe(i,rl):102-I08, 1976
(24) Fattusus S. I9ttcutn C\. Changrs of stnokmg Irxhiu xnd
(uugh iu men anohing eigorrurs with 30% NSM tohmto suh-
sliuuc. Br AIrd I 11127-I 130, 1976
70) Rtsrrl NLl, lCU.sou C. Rettt. l':\, it al: Phurna nieotine
Iesrls dt,rr smakin,K <ig:veurn wilh high, medium, and low
niecninr 1ieIds. lir \led .I 2:111-116. 1975
(If) Drp,uunrrn if Ile:dth. 6:duauiun. and lt'rlLrre: teeoage
,umkmgr A'atiorral p.nterne if igurrtt< smol+ing. agcs 12
thu,ugh B 1972 and 1971. DIIE11' Publ No. I[SA1 76-931.
lC,nlriutruo. D.C.c U.S Gott Prinr Off, 1976
172) 11u I t eus CL. lYSNutK t:L: A blind npul iu presrmive ntedi<'ine.
I.\)1.\ 23Ii:2196i ?197. 1976
(77) lt'utisvs ('.L. :\ItNotn (ai. l\'tNutx t:l.: Primary preventiun
,if luoui< disrue he;Giuning in ehildhoud'. The 'Anow your
hndy' pml;r:un: nrsign ul stud). PRrc Ned 6::361-357. 1977
Ii{{ Stutstt<v JL: A<rniral rreirtc and rvalerntion Of srnoking
,,,nuul mrrhuds. Public Ilcalilt Rep 81:d87-19I 1969
t7it tim kt tir <f, f..it Smukin8 rrssvtiuu prugcuus of tir amrriaur
llodth Euuud;niun. 19ct \Ied 5.151-171, 19711
J NATI. (I:\NCF.R INSr
